BIOBIJOU Co.,Ltd.

489460· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩11,640+3.37%

2026-09-18

Financials

Valuation Metrics

BIOBIJOU Co.,Ltd.'s Market Cap is ₩1717B. Ranked #945 of 2,421 in KR market (top 39%), #458 of 1,640 on KOSDAQ (top 28%), #105 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 45%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	171.73B KRW	KR#945/2,421 Sec#105/231
Revenue	28.49B KRW	KR#2,044/2,421 Sec#142/231
Net Income	4.15B KRW	KR#1,269/2,421 Sec#89/231
Total Assets	63.75B KRW	KR#2,069/2,421 Sec#178/231
Net Assets	61.98B KRW	KR#1,768/2,421 Sec#150/231
Value
P/E	41.36x	KR#1,383/2,421 Sec#86/231
P/B	2.77x	KR#2,089/2,421 Sec#164/231
P/S	6.03x	KR#2,187/2,421 Sec#146/231
EV/EBITDA	37.87x	KR#1,275/2,421 Sec#81/231
FCF Yield	-1.82%	KR—/2,421 Sec—/231
Profitability
ROE	6.70%	KR#918/2,421 Sec#63/231
ROA	6.51%	KR#569/2,421 Sec#45/231
Op. Margin	14.84%	KR#307/2,421 Sec#28/231
Financial Health
Debt Ratio	2.85%	KR#13/2,421 Sec#5/231
Total Debt	0 KRW	KR—/2,421 Sec—/231
FCF	-3.12B KRW	KR#1,398/2,421 Sec#109/231
Cash	11.64B KRW	KR#1,608/2,421 Sec#136/231
Current Ratio	30.20x	KR#10/2,421 Sec#5/231
Net Debt/EBITDA	-2.75x	KR#180/2,421 Sec#7/231
Dividend
Div. Yield	0.86%	KR#1,159/2,421 Sec#69/231
Performance
1Y Return	-29.45%	KR#1,549/2,421 Sec#125/231
1M Return	2.37%	KR#989/2,421 Sec#72/231
From 52W High	-36.91%	KR#795/2,421 Sec#53/231
1Y MDD	-67.41%	KR#1,859/2,421 Sec#156/231
Trading
Volume	75,624 shares	KR#928/2,421 Sec#97/231
Trading Value	883.3M KRW	KR#753/2,421 Sec#75/231
Foreign Own.	0.29%	KR#2,258/2,421 Sec#217/231
Per Share
EPS	281 KRW	KR#1,195/2,421 Sec#81/231
BPS	4,201 KRW	KR#1,624/2,421 Sec#117/231